Skip to Main content

Researcher identifiers

Export Publications

Export the displayed publications:
Number of documents

32

Eloïse Thomas - Assisant Professor


LAGEPP : Laboratory of Automatic Control, Chemical and Pharmaceutical Engineering. UMR5007 CNRS. France.

ISPB : Institute of Pharmaceutical and Biological Sciences - Faculty of Pharmacy of Lyon. France


Journal articles11 documents

  • Joshua Owen, Eloise Thomas, Jyothi Menon, Michael Gray, Irini Skaripa-Koukelli, et al.. Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. Journal of Controlled Release, Elsevier, 2020, 319, pp.222-233. ⟨10.1016/j.jconrel.2019.12.045⟩. ⟨hal-02547889⟩
  • Francois Lux, Vu Long Tran, Eloise Thomas, Sandrine Dufort, Fabien Rossetti, et al.. AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine. British Journal of Radiology, British Institute of Radiology, 2019, 92 (1093), pp.20180365. ⟨10.1259/bjr.20180365⟩. ⟨hal-01935540⟩
  • Vivek Thakare, Vu-Long Tran, Marco Natuzzi, Eloise Thomas, Mathieu Moreau, et al.. Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging. RSC Advances, Royal Society of Chemistry, 2019, 9 (43), pp.24811-24815. ⟨10.1039/C9RA00365G⟩. ⟨hal-02287597⟩
  • Eloise Thomas, Jyothi Menon, Joshua Owen, Irini Skaripa-Koukelli, Sheena Wallington, et al.. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy. Theranostics, Ivyspring International Publisher, 2019, 9 (19), pp.5595-5609. ⟨10.7150/thno.34669⟩. ⟨hal-02287691⟩
  • S. Huclier-Markai, E. Ntsiba, E. Thomas, C. Alliot, Cs Cutler, et al.. Multimodal AGuIX® Nanoparticles: Size Characterization by HF5 and Optimization of the Radiolabeling with Various SPECT/PET/Theranostic Tracers. Int.J.Med.Nano Res., 2019, 6 (1), ⟨10.23937/2378-3664.1410027⟩. ⟨hal-02317372⟩
  • Magali Toussaint, Sophie Pinel, Florent Auger, Nicolas Durieux, Magalie Thomassin, et al.. Proton MR spectroscopy and diffusion MR imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma. Theranostics, Ivyspring International Publisher, 2017, 7 (2), pp.436-451. ⟨10.7150/thno.17218⟩. ⟨hal-01399256⟩
  • Eloise Thomas, Ludovic Colombeau, Mickaël Gries, Thibaut Peterlini, Clélia Mathieu, et al.. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma. International Journal of Nanomedicine, Dove Medical Press, 2017, 12, pp.7075-7088. ⟨10.2147/IJN.S141559⟩. ⟨hal-01643075⟩
  • Penelope Bouziotis, Dimitris Stellas, Eloise Thomas, Charles Truillet, Charalampos Tsoukalas, et al.. 68 Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy. Nanomedicine, Future Medicine, 2017, 12 (13), pp.1561 - 1574. ⟨10.2217/nnm-2017-0032⟩. ⟨hal-01689547⟩
  • Alexandre Detappe, Eloise Thomas, Mark Tibbitt ||, Sijumon Kunjachan, Oksana Zavidij, et al.. Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance–Computed Tomography Image Guided Radiation Therapy. Nano Letters, American Chemical Society, 2017, 17 (3), pp.1733 - 1740. ⟨10.1021/acs.nanolett.6b05055⟩. ⟨hal-01689566⟩
  • Charles Truillet, Eloise Thomas, Francois Lux, Loc T Huynh, Olivier Tillement, et al.. Synthesis and Characterization of 89 Zr-Labeled Ultrasmall Nanoparticles. Molecular Pharmaceutics, American Chemical Society, 2016, 13 (7), pp.2596 - 2601. ⟨10.1021/acs.molpharmaceut.6b00264⟩. ⟨hal-01405878⟩
  • Lucie Sancey, Shady Kotb, C. Truillet, F. Appaix, Arthur Marais, et al.. Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection. ACS Nano, American Chemical Society, 2015, 9 (3), pp.2477-2488. ⟨10.1021/acsnano.5b00552⟩. ⟨hal-01207383⟩

Patents1 document

  • Ross Berbeco, Eloise Thomas, Francois Lux, Olivier Tillement, Alexandre Detappe, et al.. Bismuth-Gadolinium Nanoparticles. United States, Patent n° : WO2018107057A1. 2018. ⟨hal-02548425⟩

Theses1 document

  • Eloïse Thomas. Développement d’une seconde génération de nanoparticules AGuIX pour des applications théranostiques en oncologie. Cancer. Université de Lyon, 2017. Français. ⟨NNT : 2017LYSE1121⟩. ⟨tel-01674228⟩

Conference papers9 documents

  • Katherine A. Vallis, Eloise Thomas, Jyothi Menon, Joshua Owen, Sheena Wallington, et al.. Ultrasound-Induced Mircobubble Cavitation For Optimisation Of Tumour Uptake Of Liposome-Based Chemo-Radionuclide Therapy. Annual Congress of the European Association of Nuclear Medicine, Oct 2019, Barcelona, Spain. pp.1-952, ⟨10.1007/s00259-019-04486-2⟩. ⟨hal-02548480⟩
  • Noémie Thomas, Mickaël Gries, Ludovic Colombeau, Eloise Thomas, Cédric Boura, et al.. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma. International Conference on Porphyrins and Phthalocyanines, ICCP-10, Jul 2018, Munich, Germany. ⟨hal-01845326⟩
  • Ludovic Colombeau, Eloise Thomas, Noémie Thomas, Muriel Barberi-Heyob, Francois Lux, et al.. AGuIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumors. 17th Congress of the European Society for Photobiology, Sep 2017, Pise, Italy. ⟨hal-02550754⟩
  • Eloise Thomas, Magali Toussaint, Ludovic Colombeau, Mickaël Gries, Thibaut Peterlini, et al.. Gadolinium-based nanoparticles for the treatment of glioblastoma by MRI-guided photodynamic therapy. World Molecular Imaging Congress, WMIC 2017, Sep 2017, Philadelphia, United States. ⟨hal-02548177⟩
  • Eloise Thomas, Alexandre Detappe, Ross Berbeco, Francois Lux, Olivier Tillement. Functionalization of AGuIX nanoparticles for improved radiotherapy. Nano-Hybrides n°14, May 2017, Bastia, France. ⟨hal-02548188⟩
  • Magali Toussaint, Florent Auger, Sophie Pinel, Magalie Thomassin, Eloise Thomas, et al.. Use of MR Imaging and proton MR Spectroscopy imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma. Photodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. ⟨hal-01407476⟩
  • Magali Toussaint, Florent Auger, Sophie Pinel, Nicolas Durieux, Magalie Thomassin, et al.. Interstitial photodynamic therapy for glioblastoma: interest of MRI monitoring to predict iPDT effects.. 13e Colloque Nano-hybrides, ILM, Lyon 1, May 2016, Porquerolles, France. ⟨hal-01312929⟩
  • Eloise Thomas, Francois Lux, Olivier Tillement. Ultrasmall nanoparticles functionalization for PET and SPECT imaging. Nano-Hybrides n°12, May 2015, Bastia, France. ⟨hal-02548199⟩
  • Francois Lux, Lucie Sancey, Eloise Thomas, Olivier Tillement. AGuIX nanoparticles for PET/MRI. France Life Imaging, Dec 2014, Lyon, France. ⟨hal-02548210⟩

Poster communications10 documents

  • Eloise Thomas, Jyothi Menon, Joshua Owen, Sheena Wallington, Michael Gray, et al.. Ultrasound And Microbubbles Enhance The Delivery Of A Liposomal Formulation For Targeted Chemo-Radionuclide Therapy. British Nuclear Medicine Society Spring Meeting, Apr 2019, Oxford, United Kingdom. ⟨hal-02548236⟩
  • Eloise Thomas, Jyothi Menon, Joshua Owen, Sheena Wallington, Michael Gray, et al.. Ultrasound-Mediated Cavitation To Enhance The Delivery Of Liposomal Formulations For Targeted Radionuclide Therapy. Controlled Release Society Annual Meeting, Jul 2019, Valencia, Spain. ⟨hal-02548225⟩
  • Eloise Thomas, Jyothi Menon, Joshua Owen, Irini Skaripa-Koukelli, Robert Carlisle, et al.. Targeted and combined chemo-radionucleide therapy for the treatment of breast cancers. CRUK Symposium, Jun 2018, Oxford, United Kingdom. ⟨hal-02548247⟩
  • Joshua Owen, Jyothi Menon, Eloise Thomas, Irini Skaripa-Koukelli, Martin Gill, et al.. Indium-111 afterloading of preformed EGF containing liposomes for molecularly targeted radionuclide delivery via ultrasound induced cavitation.. Annual Congress of the European Association of Nuclear Medicine, Oct 2018, Düsseldorf, Germany. European Journal of Nuclear Medicine and Molecular Imaging, 45 (S1), pp.1-844, 2019, ⟨10.1007/s00259-018-4148-3⟩. ⟨hal-02548464⟩
  • Eloise Thomas, Charles Truillet, Franck Denat, Francois Lux, Frederic Boschetti, et al.. Radiolabeling for long term biodistribution of ultrasmall nanoparticles designed for radiotherapy guided by MRI. World Molecular Imaging Congress, Sep 2016, New-York, United States. ⟨hal-02548258⟩
  • E Thomas, M Toussaint, Ludovic Colombeau, Céline Frochot, Régis Vanderesse, et al.. Ultrasmall gadolinium-based nanoparticles designed for photodynamic therapy (PDT) guided by MRI. Photodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. Photodiagnosis and Photodynamic Therapy, 17, pp.A60, 2017, ⟨10.1016/j.pdpdt.2017.01.136⟩. ⟨hal-01498485⟩
  • Ludovic Colombeau, Eloise Thomas, Thibaut Peterlini, Mickaël Gries, Noémie Thomas, et al.. AGUIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumors. Photodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. Photodiagnosis and Photodynamic Therapy, 17, pp.A71, 2017, ⟨10.1016/j.pdpdt.2017.01.161⟩. ⟨hal-01408883⟩
  • Marie-Caline Abadjian, Eloise Thomas, Joseph Latoche, Lesley Foley, Kathryn Day, et al.. PET and MR imaging with 64Cu/68Ga-labeled AGuIX ultra-small nanoparticles in tumor-bearing mice. SNMMI Annual Meeting, Jun 2016, San Diego, United States. Journal of Nuclear Medicine, 57 (Supplement2), pp.1181, 2016. ⟨hal-02548345⟩
  • Eloise Thomas, Frederic Boschetti, Franck Denat, Francois Lux, Olivier Tillement. Functionalization of ultrasmall nanoparticles for theranosctic applications. COST TD1004 Action Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging-Guided Drug Delivery, Oct 2015, Belgrade, Serbia. ⟨hal-02548269⟩
  • Eloise Thomas, Charles Truillet, Marie Plissonneau, Frederic Boschetti, Franck Denat, et al.. AGuIX modifications for active tumor targeting and radiolabelling. COST TD1004 Action Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging-Guided Drug Delivery, Oct 2014, Istanbul, Turkey. ⟨hal-02548293⟩